The American Journal of Medicine
Volume 123, Issue 6 , Pages 514-516 , June 2010

Pokes, Papules, Plaques

  • Daniel G. Federman, MD

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, Conn
    • Corresponding Author InformationRequests for reprints should be addressed to Daniel G. Federman, MD, VA Connecticut Healthcare System (11ACSL), 950 Campbell Ave., West Haven, CT 06516
  • ,
  • Jeffrey D. Kravetz, MD

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Susan S. Kashaf, MPH, MD

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Robert S. Kirsner, MD, PhD

      Affiliations

    • Department of Dermatology, University of Miami Miller School of Medicine, Miami, Fla

References 

  1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population (National Health and Nutrition Examination Survey 1999-2002). Diabetes Care. 2006;29:1263–1268
  2. Danaei G, Friedman AB, Osa S, et al. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr. 2009;7:16
  3. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56:629–634
  4. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–835
  5. Shelling ML, Federman DG, Prodanovich S, Kirsner RS. Psoriasis and vascular disease: an unsolved mystery. Am J Med. 2008;121:360–365
  6. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–1741
  7. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular disease and mortality. Arch Dermatol. 2009;145:700–703
  8. Vardar B, Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract. 2007;77:231–236
  9. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4:661–667
  10. Anderson JA, Adkinson F. Allergic reactions to drugs and biologic agents. JAMA. 1987;258:2891–2899
  11. Yumlu S, Barany R, Eriksson M, Röcken C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol. 2009;40:1655–1660
  12. Moore AF, Soper T, Jones N, et al. Psoriatic exacerbation associated with insulin therapy. Diabetes Care. 2008;31:e31

 Parwathi “Uma” Paniker, MD, Section Editor

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest regarding the manuscript contents.

 Authorship: All authors have reviewed and approved this submission and take responsibility for its content.

PII: S0002-9343(10)00230-5

doi: 10.1016/j.amjmed.2010.03.005

The American Journal of Medicine
Volume 123, Issue 6 , Pages 514-516 , June 2010